Clinical Trials Browser

INDUSTRY × Lymphoma, Large B-Cell, Diffuse × TAK-659 × Clear all

NCT03123393 2023-02-08

TAK-659 in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Phase 2 Terminated

49 enrolled 12 charts

Lymphoma, Large B-Cell, Diffuse

NCT03357627 2023-02-08

A Study of TAK-659 in Combination With Venetoclax for Adult Participants With Previously Treated Non-Hodgkin Lymphoma

Phase 1 Completed

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse